Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)

Jiangsu CoWin Biotech Revenue

Jiangsu CoWin Biotech had revenue of 59.00M CNY in the quarter ending March 31, 2026, with 37.19% growth. This brings the company's revenue in the last twelve months to 209.51M, up 49.57% year-over-year. In the year 2025, Jiangsu CoWin Biotech had annual revenue of 193.52M with 53.74% growth.

• Revenue (ttm): 209.51M
• Revenue Growth: +49.57%
• P/S Ratio: 11.14
• Revenue / Employee: 251.51K
• Employees: 770
• Market Cap: 2.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	193.52M	67.64M	53.74%
Dec 31, 2024	125.88M	-45.47M	-26.54%
Dec 31, 2023	171.34M	-350.26M	-67.15%
Dec 31, 2022	521.60M	183.14M	54.11%
Dec 31, 2021	338.46M	105.25M	45.13%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error